ArticleArchives of pharmacal research2024

Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition.

Yu-Li Lo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.